Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-10 Exercise |
2020-08-12 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
7,000 | $31.59 | 900,839 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 5:02 pm |
N/A 2026-02-08 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
91,000 | $0 | 900,839 (Direct) |
View |
| 2020-08-11 Gift |
2020-08-12 4:38 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
1,560 | $0 | 11,887,429 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-31 4:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $160.4 | 980,502 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-31 4:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 980,502 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-31 4:24 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
39,000 | $0 | 980,502 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 5:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
14,584,180 | $14.23 | 30,745,118 (Indirect) |
View |
| 2020-07-15 Option Award |
2020-07-16 5:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
29,614,832 | $14.23 | 236,249,845 (Direct) |
View |
Ownership |
2020-07-14 09:00 am |
N/A N/A |
BeiGene Ltd. | BGNE | HILLHOUSE CAPITAL ADVISORS LTD. HILLHOUSE CAPITAL MANAGEMENT LTD. 10% Owner |
0 | $0 | 147,035,258 (Indirect) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
3,921 | $160.4 | 558,427 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:43 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
50,973 | $0 | 558,427 (Direct) |
View |
| 2020-06-26 Exercise |
2020-06-30 4:14 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
2,079 | $160.4 | 1,070,475 (Direct) |
View |
| 2020-06-29 Exercise |
2020-06-30 4:14 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 1,070,475 (Direct) |
View |
| 2020-06-26 Exercise |
2020-06-30 4:14 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
46,527 | $0 | 1,070,475 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 5:14 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
90,766 | $0 | 90,766 (Indirect) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:31 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
45,383 | $0 | 45,383 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:23 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director |
45,383 | $0 | 45,383 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:20 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
45,383 | $0 | 3,543,061 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:18 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | su Jingshyh S Director |
45,383 | $0 | 45,383 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:17 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Malley Thomas Director |
45,383 | $0 | 45,383 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
45,383 | $0 | 45,383 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
560,599 | $0 | 560,599 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:13 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
321,724 | $0 | 605,188 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:11 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
371,228 | $0 | 487,656 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:09 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | Wu Xiaobin President & GM China |
890,968 | $0 | 2,290,748 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:06 pm |
N/A 2030-06-16 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,821,976 | $0 | 1,821,976 (Direct) |
View |
| 2020-05-29 Exercise |
2020-06-02 4:11 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 772,242 (Direct) |
View |
| 2020-05-29 Exercise |
2020-06-02 4:11 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 772,242 (Direct) |
View |